Famotidine and Lockdowns - COVID Solutions?

The world of COVID-19 is always changing. Join Geoff Wall for a rapid fire of updates regarding famotidine, lockdowns, and ivermectin as evaluated for efficacy in COVID-19.The GameChangersThe use of high-dose famotidine in the treatment of COVID-19 has demonstrated moderate safety, but questionable efficacy. Additionally, a recent meta-analysis examining the efficacy of lockdown on the spread of COVID-19 had several limitations that should be taken into consideration. Show Segments00:00 – Introductions01:56 – Famotidine in the Treatment of COVID-1910:52 – Effects of Lockdown on COVID-19 Mortality 18:26 – Ivermectin Treatment of COVID-19 in High-Risk Patients 23:45 – Closing Remarks HostGeoff Wall, PharmD., BCPS, FCCP, CGPProfessor of Pharmacy Practice, Drake UniversityInternal Medicine/Critical Care, UnityPoint HealthRedeem your CPE or CME credit here!Pharmacist membersCMENeed a membership?Join for CPE CreditJoin for CME Credit References and resources:References and resources:1.     Oral Famotidine Versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blind, Data-Intense, Phase 2 Clinical Trial 2.     A Literature Review and Meta-Analysis of the Effects of Lockdowns on COVID-19 Mortality. Pre-Publication.3.     Efficacy of Ivermectin Treatment on Disease Progression Among Adults with Mild to Moderate COVID-19 and ComorbiditiesContinuing Education Information:Learning Objectives:1. Describe the latest information on masks and other non-pharmacologic interventions to halt the spread of COVID-192. Discuss the recent randomized controlled trial evaluating famotidine use in early COVID-19 positive patientsDr. Wall is a member of the Janssen Speaker's Bureau.0.05 CEU | 0.5 HrsACPE UAN: 0107-0000-22-142-H01-PInitial release date: 03/28/22Expiration date: 03/28/2023Follow CEimpact on Social Media:LinkedInInstagram